Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 235

1.

Adenocarcinoma of the duodenum: factors influencing long-term survival.

Sohn TA, Lillemoe KD, Cameron JL, Pitt HA, Kaufman HS, Hruban RH, Yeo CJ.

J Gastrointest Surg. 1998 Jan-Feb;2(1):79-87.

PMID:
9841972
[PubMed - indexed for MEDLINE]
2.

Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators.

Sohn TA, Yeo CJ, Cameron JL, Koniaris L, Kaushal S, Abrams RA, Sauter PK, Coleman J, Hruban RH, Lillemoe KD.

J Gastrointest Surg. 2000 Nov-Dec;4(6):567-79.

PMID:
11307091
[PubMed - indexed for MEDLINE]
3.

Pancreaticoduodenectomy for cancer of the head of the pancreas. 201 patients.

Yeo CJ, Cameron JL, Lillemoe KD, Sitzmann JV, Hruban RH, Goodman SN, Dooley WC, Coleman J, Pitt HA.

Ann Surg. 1995 Jun;221(6):721-31; discussion 731-3.

PMID:
7794076
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

The lymph node ratio is the strongest prognostic factor after resection of pancreatic cancer.

Riediger H, Keck T, Wellner U, zur Hausen A, Adam U, Hopt UT, Makowiec F.

J Gastrointest Surg. 2009 Jul;13(7):1337-44. doi: 10.1007/s11605-009-0919-2. Epub 2009 May 6.

PMID:
19418101
[PubMed - indexed for MEDLINE]
5.

What prognostic factors are important in duodenal adenocarcinoma?

Bakaeen FG, Murr MM, Sarr MG, Thompson GB, Farnell MB, Nagorney DM, Farley DR, van Heerden JA, Wiersema LM, Schleck CD, Donohue JH.

Arch Surg. 2000 Jun;135(6):635-41; discussion 641-2.

PMID:
10843358
[PubMed - indexed for MEDLINE]
6.

Adenocarcinoma of the head of the pancreas: effects of surgical and nonsurgical therapy on survival--a ten-year experience.

Carr JA, Ajlouni M, Wollner I, Wong D, Velanovich V.

Am Surg. 1999 Dec;65(12):1143-9.

PMID:
10597062
[PubMed - indexed for MEDLINE]
7.

Long-term survival after pancreatoduodenectomy for pancreatic adenocarcinoma: is cure possible?

Schnelldorfer T, Ware AL, Sarr MG, Smyrk TC, Zhang L, Qin R, Gullerud RE, Donohue JH, Nagorney DM, Farnell MB.

Ann Surg. 2008 Mar;247(3):456-62. doi: 10.1097/SLA.0b013e3181613142.

PMID:
18376190
[PubMed - indexed for MEDLINE]
8.

Pancreaticoduodenectomy. Does it have a role in the palliation of pancreatic cancer?

Lillemoe KD, Cameron JL, Yeo CJ, Sohn TA, Nakeeb A, Sauter PK, Hruban RH, Abrams RA, Pitt HA.

Ann Surg. 1996 Jun;223(6):718-25; discussion 725-8.

PMID:
8645045
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Extent of resection in the management of duodenal adenocarcinoma.

Kaklamanos IG, Bathe OF, Franceschi D, Camarda C, Levi J, Livingstone AS.

Am J Surg. 2000 Jan;179(1):37-41.

PMID:
10737576
[PubMed - indexed for MEDLINE]
10.

Primary duodenal adenocarcinoma: a ten-year experience with 79 patients.

Rose DM, Hochwald SN, Klimstra DS, Brennan MF.

J Am Coll Surg. 1996 Aug;183(2):89-96.

PMID:
8696551
[PubMed - indexed for MEDLINE]
11.

Prognostic factors for primary duodenal adenocarcinoma.

Lee HG, You DD, Paik KY, Heo JS, Choi SH, Choi DW.

World J Surg. 2008 Oct;32(10):2246-52. doi: 10.1007/s00268-008-9678-6.

PMID:
18668288
[PubMed - indexed for MEDLINE]
12.

Reexploration for periampullary carcinoma: resectability, perioperative results, pathology, and long-term outcome.

Sohn TA, Lillemoe KD, Cameron JL, Pitt HA, Huang JJ, Hruban RH, Yeo CJ.

Ann Surg. 1999 Mar;229(3):393-400.

PMID:
10077052
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Surgical palliation of unresectable periampullary adenocarcinoma in the 1990s.

Sohn TA, Lillemoe KD, Cameron JL, Huang JJ, Pitt HA, Yeo CJ.

J Am Coll Surg. 1999 Jun;188(6):658-66; discussion 666-9.

PMID:
10359359
[PubMed - indexed for MEDLINE]
14.

Factors influencing survival after resection for periampullary neoplasms.

Bouvet M, Gamagami RA, Gilpin EA, Romeo O, Sasson A, Easter DW, Moossa AR.

Am J Surg. 2000 Jul;180(1):13-7.

PMID:
11036132
[PubMed - indexed for MEDLINE]
15.

Does intraoperative radiation therapy improve local tumor control in patients undergoing pancreaticoduodenectomy for pancreatic adenocarcinoma? A propensity score analysis.

Showalter TN, Rao AS, Rani Anne P, Rosato FE, Rosato EL, Andrel J, Hyslop T, Xu X, Berger AC.

Ann Surg Oncol. 2009 Aug;16(8):2116-22. doi: 10.1245/s10434-009-0498-1. Epub 2009 May 13.

PMID:
19437078
[PubMed - indexed for MEDLINE]
16.

Primary adenocarcinoma of third and fourth portions of duodenum. Favorable prognosis after resection.

Lowell JA, Rossi RL, Munson JL, Braasch JW.

Arch Surg. 1992 May;127(5):557-60.

PMID:
1349472
[PubMed - indexed for MEDLINE]
17.

Pancreaticoduodenectomy: a 20-year experience in 516 patients.

Schmidt CM, Powell ES, Yiannoutsos CT, Howard TJ, Wiebke EA, Wiesenauer CA, Baumgardner JA, Cummings OW, Jacobson LE, Broadie TA, Canal DF, Goulet RJ Jr, Curie EA, Cardenes H, Watkins JM, Loehrer PJ, Lillemoe KD, Madura JA.

Arch Surg. 2004 Jul;139(7):718-25; discussion 725-7.

PMID:
15249403
[PubMed - indexed for MEDLINE]
18.

Is duodenal invasion a relevant prognosticator in patients undergoing adjuvant chemoradiotherapy for distal common bile duct cancer?

Kim K, Chie EK, Jang JY, Kim SW, Oh DY, Im SA, Kim TY, Bang YJ, Ha SW.

Int J Radiat Oncol Biol Phys. 2010 Jul 15;77(4):1186-90. doi: 10.1016/j.ijrobp.2009.06.033. Epub 2009 Dec 4.

PMID:
19962835
[PubMed - indexed for MEDLINE]
19.

Adjuvant concurrent chemoradiation for adenocarcinoma of the distal common bile duct.

Hughes MA, Frassica DA, Yeo CJ, Riall TS, Lillemoe KD, Cameron JL, Donehower RC, Laheru DA, Hruban RH, Abrams RA.

Int J Radiat Oncol Biol Phys. 2007 May 1;68(1):178-82. Epub 2007 Feb 2.

PMID:
17276614
[PubMed - indexed for MEDLINE]
20.

Postoperative morbidity and long-term survival after pancreaticoduodenectomy with superior mesenterico-portal vein resection.

Riediger H, Makowiec F, Fischer E, Adam U, Hopt UT.

J Gastrointest Surg. 2006 Sep-Oct;10(8):1106-15.

PMID:
16966029
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk